Executive perspective

Media statement on COVID-19 vaccine distribution support in California

Starting the week of August 23rd, AmerisourceBergen will support the State of California in distributing Pfizer-BioNTech COVID-19 vaccines to small physician practices. This collaboration will support small public and private physician practices enrolled in the state’s COVID-19 vaccination program that elect to receive smaller or minimum quantities of the vaccine. This collaboration will support many local health jurisdictions currently undertaking local redistribution efforts, relieving some capacity and workloads.

Based on projected demand from small physician offices, AmerisourceBergen and the California Department of Public Health (CDPH) will place bulk orders with the CDC, and product will be stored at AmerisourceBergen’s specialty distribution center, for fulfillment of small Pfizer orders. AmerisourceBergen, as an approved COVID-19 redistributor within the California COVID-19 Program, will ship out smaller quantities of the Pfizer-BioNTech COVID-19 vaccines, depending on what’s needed, directly to healthcare facilities.

AmerisourceBergen is proud to leverage its strong capabilities and expertise handling specialty pharmaceuticals to assist California as the state supplies small physician practices in the COVID-19 vaccination movement. As an exclusive distributor for select COVID-19 therapies, AmerisourceBergen has been working closely with state health departments, so this is a natural extension of AmerisourceBergen’s ongoing role in supporting COVID-19 pandemic response.
 

Press release

IntrinsiQ Specialty Solutions Expands Data Capabilities, Empowering Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

October 16, 2025

Media statement

Cencora to Support Commercial Launch of Precigen’s Novel Immunotherapy in the United States

September 24, 2025

Media mention

ThoughtSpot 2025 Highlights Cencora’s Commitment to Advancing the Future of Pharmacy and Ensuring Medication Access

August 27, 2025

Media contacts

Need help or have questions?  Send us a message and we'll get back to you soon.

Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.

Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.